HLA-mismatched renal transplantation without maintenance immunosuppression

New England Journal of Medicine

Volumn 358, Issue 4, 2008, Pages 353-361

  Kawai, Tatsuo ^a   Cosimi, A Benedict ^a   Spitzer, Thomas R ^a   Tolkoff Rubin, Nina ^a   Suthanthiran, Manikkam ^b   Saidman, Susan L ^a   Shaffer, Juanita ^a   Preffer, Frederic I ^a   Ding, Ruchuang ^b   Sharma, Vijay ^b   Fishman, Jay A ^a   Dey, Bimalangshu ^a   Ko, Dicken S C ^a   Hertl, Martin ^a   Goes, Nelson B ^a   Wong, Waichi ^a   Williams Jr , Winfred W ^a   Colvin, Robert B ^a   Sykes, Megan ^a   Sachs, David H ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; GRANZYME B; MESSENGER RNA; PREDNISONE; RITUXIMAB; SIPLIZUMAB; TRANSCRIPTION FACTOR FOXP3; FOXA1 PROTEIN, HUMAN; GRANZYME; HEPATOCYTE NUCLEAR FACTOR 3ALPHA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CAPILLARY LEAK SYNDROME; CLINICAL ARTICLE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; GRAFT RECIPIENT; HISTOCOMPATIBILITY; HLA SYSTEM; HUMAN; HUMAN CELL; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY DONOR; KIDNEY FAILURE; KIDNEY FUNCTION TEST; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVING DONOR; MALE; NONMYELOABLATIVE CONDITIONING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TREATMENT WITHDRAWAL; ALLOTRANSPLANTATION; BIOPSY; BONE MARROW TRANSPLANTATION; CHRONIC KIDNEY FAILURE; GENETICS; GRAFT REJECTION; HISTOCOMPATIBILITY TEST; HISTOLOGY; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; ISOLATION AND PURIFICATION; KIDNEY; METABOLISM; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; T LYMPHOCYTE; TRANSPLANTATION TOLERANCE; ULTRASTRUCTURE;

ADULT; BIOPSY; BONE MARROW TRANSPLANTATION; COMBINED MODALITY THERAPY; FEMALE; GRAFT REJECTION; GRANZYMES; HEPATOCYTE NUCLEAR FACTOR 3-ALPHA; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOSUPPRESSION; KIDNEY; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RNA, MESSENGER; T-LYMPHOCYTES; TRANSPLANTATION CHIMERA; TRANSPLANTATION CONDITIONING; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HOMOLOGOUS;

EID: 38549088096     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa071074     Document Type: Article

References (28)

1. Pascual M, Theruvath T, Kawai T, Tolkoff-Rubin N, Cosimi AB. Strategies to improve long-term outcomes after renal transplantation. N Engl J Med 2002;346:580-90.
2. Sayegh MH, Carpenter CB. Transplantation 50 years later - progress, challenges, and promises. N Engl J Med 2004;351:2761-6.
3. Murray JE, Merrill JP, Dammin GJ, et al. Study on transplantation immunity after total body irradiation: clinical and experimental investigation. Surgery 1960;48:272-84.
4. Barber WH, Mankin JA, Laskow DA, et al. Long-term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allograft recipients. Transplantation 1991;51:70-5.
5. Millan MT, Shizuru JA, Hoffmann P, et al. Mixed chimerism and immunosuppressive drug withdrawal after HLA-mismatched kidney and hematopoietic progenitor transplantation. Transplantation 2002;73:1386-91.
6. Shapiro R, Basu A, Tan H, et al. Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with thymoglobulin or campath. J Am Coll Surg 2005;200:505-15.
7. Kirk AD, Mannon RB, Kleiner DE, et al. Results from a human renal allograft tolerance trial evaluating T-cell depletion with alemtuzumab combined with deoxyspergualin. Transplantation 2005;80:1051-9.
8. Sharabi Y, Sachs DH. Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen. J Exp Med 1989;169:493-502.
9. Fuchimoto Y, Huang CA, Yamada K, et al. Mixed chimerism and tolerance without whole body irradiation in a large animal model. J Clin Invest 2000;105:1779-89.
10. Kawai T, Cosimi AB, Colvin RB, et al. Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys. Transplantation 1995;59:256-62.
11. Kimikawa M, Sachs DH, Colvin RB, Bartholomew A, Kawai T, Cosimi AB. Modifications of the conditioning regimen for achieving mixed chimerism and donor-specific tolerance in cynomolgus monkeys. Transplantation 1997;64:709-16.
12. Kawai T, Poncelet A, Sachs DH, et al. Long-term outcome and alloantibody production in a non-myeloablative regimen for induction of renal allograft tolerance. Transplantation 1999;68:1767-75.
13. Kawai T, Sogawa H, Boskovic S, et al. CD154 blockade for induction of mixed chimerism and prolonged renal allograft survival in nonhuman primates. Am J Transplant 2004;4:1391-8.
14. Spitzer TR, Delmonico F, Tolkoff-Rubin N, et al. Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohematopoietic chimerism. Transplantation 1999;68:480-4.
15. Bühler LH, Spitzer TR, Sykes M, et al. Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease. Transplantation 2002;74:1405-9.
16. Fudaba Y, Spitzer TR, Shaffer J, et al. Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analyses. Am J Transplant 2006;6:2121-33.
17. Schwartz DW, Glock B, Jungl EM, Mayr WR. Strategy to detect chimerism in allogeneic bone marrow transplant recipients by PCR-amplification fragment length polymorphism analysis of microsatellite polymorphisms. Vox Sang 1995;68:139-43.
18. Muthukumar T, Dadhania D, Ding R, et al. Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med 2005;353:2342-51.
19. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003;299:1057-61.
20. Starzl TE, Demetris AJ. Transplantation tolerance, microchimerism, and the two-way paradigm. Theor Med Bioeth 1998;19:441-55.
21. Ciancio G, Burke GW, Garcia-Morales R, et al. Effect of living-related donor bone marrow infusion on chimerism and in vitro immunoregulatory activity in kidney transplant recipients. Transplantation 2002;74:488-96.
22. Corry RJ, Chakrabarti PK, Shapiro R, et al. Simultaneous administration of adjuvant donor bone marrow in pancreas transplant recipients. Ann Surg 1999;230:372-9.
23. Mezrich JD, Yamada K, Lee RS, et al. Induction of tolerance to heart transplants by simultaneous cotransplantation of donor kidneys may depend on a radiation-sensitive renal-cell population. Transplantation 2003;76:625-31.
24. Lee I, Wang L, Wells AD, Dorf ME, Ozkaynak E, Hancock WW. Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor. J Exp Med 2005;201:1037-44.
25. Sayegh MH. Why do we reject a graft? Role of indirect allorecognition in graft rejection. Kidney Int 1999;56:1967-79.
26. Spitzer TR. Engraftment syndrome following hematopoietic stem cell transplantation. Bone Marrow Transplant 2001;27:893-8.
27. Mengel M, Bogers J, Bosmans JL, et al. Incidence of C4d stain in protocol biopsies from renal allografts: results from a multicenter trial. Am J Transplant 2005;5:1050-6.
28. Haas M, Rahman MH, Racusen LC, et al. C4d and C3d staining in biopsies of ABO- and HLA-incompatible renal allografts: correlation with histologic findings. Am J Transplant 2006;6:1829-40.